Meet The Team How-Tos Our Supporters How to Participate in Precision Panc Membership Meeting Minutes Remit of Steering Committee Patient Stories Documents Working with the NHS Patient Public Engagement Meetings Governance News Clinicians Area Clinical Trials What is precision medicine? Information and Support What is Pancreatic Cancer? Current Research Our Researchers Privacy Policy Patients and Carers Contact Us About us Home
Please watch this very moving video from NIHR West of England Exciting week for the Precision-Panc project Glasgow to host Pancreatic Symposium – Friday 21st May 2021 Survey on the impact of COVID-19 pandemic on pancreatic cancer research Precision-Panc in the Press Precision-Panc / PRIMUS 002 Opens a new site Precision-Panc Re-opens to Recruitment Information on COVID-19 and Pancreatic Cancer from PCUK Precision-Panc and PRIMUS studies suspended to recruitment Precision-Panc Recruits Patient 300 Paul Taylor tells us about his Precision-Panc experience Precision-Panc help raise funds for Pancreatic Cancer Scotland Precision-Panc Recruits Patient 250 Marking World Pancreatic Cancer Day Precision-Panc working with myTomorrows Precision-Panc Roundtable Final Report New Glasgow Cancer Assays by GPOL and Agilent Technologies Precision-Panc opens site 25! Precision-Panc Summer Newsletter Precision-Panc Recruits Patient 200! Precision-Panc Brochure Royal Bournemouth Hospital Opens Finding the right treatment for the patient CRUK animate the Precision-Panc platform CRUK / Precision-Panc Video Professor Biankin receives the Order of Australia in Queen’s Birthday Honours Precision-Panc opens its 20th Site Precision Panc Spring Newsletter Precision-Panc Opens Site 19 Recent Media Pieces Regarding 100 Patient Milestone Site 17 opens for Precision-Panc PRIMUS 002 opens Informing the Future of Genomic Medicine in Scotland Report is Published St James’s University Hospital Opens Precision-Panc Opens its 15th site Glasgow Experts Lead UK Pancreatic Cancer Research 11th site opens to PRECISION-Panc Scotsman Conferences Blogspot November is Pancreatic Cancer Awareness Month First Precision-Panc Trial Opens In Glasgow Cancer Research UK Investment Landscape of pancreatic neuroendocrine cancer Whole Genome Sequencing from EUS biopsies Upcoming Pancreas 2016 Conference Scottish Genome Partnership Announced Identification of four Pancreatic Cancer subtypes offers new treatment insight into the disease First Minister announces £4m ‘Precision Medicine Ecosystem’
Home | News | Survey on the impact of COVID-19 pandemic on pancreatic cancer research

Survey on the impact of COVID-19 pandemic on pancreatic cancer research

Published: 29th October 2020

The COVID-19 pandemic is causing major problems to cancer research. The risk is the disruption of progress made over the last few years with dramatic consequences on patient care and outcomes. This is particularly serious for pancreatic cancer, the deadliest solid tumour, for which accelerating research is tremendously important.

The Glasgow Precision Oncology Laboratory (GPOL – University of Glasgow), in collaboration with the Italian Pancreatic Cancer Community (I-PCC), the Pancreas Institute of Verona (University of Verona), and the Preclinical Dutch Pancreatic Cancer Group (DPCG – Netherlands) launched a survey to investigate the current and expected impact of COVID-19 pandemic on pancreatic cancer research worldwide.

The survey is addressed to group leaders/principal investigators working on preclinical and translational research in academic and non-academic research institutes and is part of a wider project evaluating the consequences of pandemic on pancreatic cancer through a transversal, transdisciplinary approach.

This evidence will inform the design of interventions to guarantee research and protect researchers. Considering the current situation, possible second lockdowns in many countries, and the persistence of COVID-19 pandemic for an indefinite time, these actions will be important to prevent the potential dramatic long-term consequences on pancreatic cancer research.

We invite all group leaders/principal investigators involved in pancreatic cancer preclinical/translational research to respond to this short survey (fewer than 3 minutes).


For more information about this research please contact Dr. Raffaella Casolino pancacovid@gmail.com

© 2021 Precision Panc
Web design by Creatomatic
This site uses cookies.
Read our privacy policy

This site uses cookies for marketing, personalisation, and analysis purposes. You can opt out of this at any time or view our full privacy policy for more information.